TY - JOUR
T1 - Strategies for primary HIV prevention that target behavioral change
AU - Safren, Steven A.
AU - Wingood, Gina
AU - Altice, Frederick L.
N1 - Funding Information:
Potential conflicts of interest. F.L.A. has received grant and/or research support from Boehringer Ingelheim and has served on the speakers bureaus of Merck, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Abbott, Tibotec, and Gilead. S.A.S. and G.W.: no conflicts.
Funding Information:
The “Opportunities for Improving HIV Diagnosis, Prevention & Access to Care in the U.S.” conference was sponsored by the American Academy of HIV Medicine, amfAR, the Centers for Disease Control and Prevention, the Forum for Collaborative HIV Research, the HIV Medicine Association of the Infectious Diseases Society of America, and the National Institute of Allergy and Infectious Diseases. Funding for the conference was supplied through an unrestricted educational grant from Gilead Sciences, amfAR, GlaxoSmithKline, Pfizer, Abbott Virology, OraSure Technologies, Roche Diagnostics, and Trinity Biotech.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/12/15
Y1 - 2007/12/15
N2 - In the absence of a vaccine or cure, behavioral change remains the major method to prevent transmission of the human immunodeficiency virus (HIV). Public awareness campaigns that disseminate information about the risks and routes of transmission, although important, have an insufficient influence on the behavioral changes essential to reduce the risk of HIV infection. Because of the complex interplay of cultural and psychosocial influences that guides human behavior, specific programs to decrease high-risk behavior have been developed for target populations. In this report, tested initiatives for preventing HIV infection are summarized and their success evaluated for men who have sex with men, injection drug users, and women of minority racial groups. Objective evidence of reductions in high-risk behavior in these 3 groups, which account for the majority of HIV transmissions in the United States, has critical implications for reducing the overall rate of new HIV infections.
AB - In the absence of a vaccine or cure, behavioral change remains the major method to prevent transmission of the human immunodeficiency virus (HIV). Public awareness campaigns that disseminate information about the risks and routes of transmission, although important, have an insufficient influence on the behavioral changes essential to reduce the risk of HIV infection. Because of the complex interplay of cultural and psychosocial influences that guides human behavior, specific programs to decrease high-risk behavior have been developed for target populations. In this report, tested initiatives for preventing HIV infection are summarized and their success evaluated for men who have sex with men, injection drug users, and women of minority racial groups. Objective evidence of reductions in high-risk behavior in these 3 groups, which account for the majority of HIV transmissions in the United States, has critical implications for reducing the overall rate of new HIV infections.
UR - http://www.scopus.com/inward/record.url?scp=40949113259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40949113259&partnerID=8YFLogxK
U2 - 10.1086/522554
DO - 10.1086/522554
M3 - Review article
C2 - 18190303
AN - SCOPUS:40949113259
VL - 45
SP - S300-S307
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - SUPPL. 4
ER -